Invention Grant
- Patent Title: Methods of reducing blood glucose or triglyceride levels by administration of METRNL protein
-
Application No.: US15729420Application Date: 2017-10-10
-
Publication No.: US10342852B2Publication Date: 2019-07-09
- Inventor: Chaoyu Miao , Zhiyong Li , Pei Wang
- Applicant: Chaoyu Miao , Zhiyong Li , Pei Wang
- Applicant Address: CN Shanghai CN Shanghai CN Shanghai
- Assignee: Chaoyu Miao,Zhiyong Li,Pei Wang
- Current Assignee: Chaoyu Miao,Zhiyong Li,Pei Wang
- Current Assignee Address: CN Shanghai CN Shanghai CN Shanghai
- Agency: Banner & Witcoff, Ltd.
- Priority: CN201310525181 20131029; CN201310525184 20131029
- Main IPC: A61K38/19
- IPC: A61K38/19 ; C07K14/52 ; A61K38/22 ; A23L33/17 ; A61K39/00 ; C07K14/475
Abstract:
The present invention provides an application of Metrnl protein in preparing a hypolipidemic, hypoglycemic medicine or dietary supplement. The present invention further provides a method for preparing a mouse with fat-specific overexpression of Metrnl.
Public/Granted literature
- US20180030102A1 APPLICATION OF METRNL PROTEIN IN PREPARING HYPOLIPIDEMIC, HYPOGLYCEMIC MEDICINE Public/Granted day:2018-02-01
Information query
IPC分类:
